ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 5176

$1.48M Total Retail Price of All Prescriptions

Rank: 110 out of 5176

309 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 309 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

56% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 623 565 1 15
METOPROLOL SUCCINATE 614 598 2 11
RANEXA 501 471 3 167
FUROSEMIDE 495 479 4 8
NEXIUM 485 465 5 16
AMLODIPINE BESYLATE 484 464 6 2
ZOLPIDEM TARTRATE 434 419 7 17
PLAVIX 402 393 8 29
ISOSORBIDE MONONITRATE ER 369 346 9 44
TAMSULOSIN HCL 365 347 10 20
COUMADIN 365 344 10 112
CARVEDILOL 362 324 12 24
SYNTHROID 357 345 13 33
ATORVASTATIN CALCIUM 300 292 14 9
JANUMET 271 255 15 77
CLOPIDOGREL 257 236 16 26
ATENOLOL 247 239 17 12
JANUVIA 242 218 18 25
DIOVAN 234 234 19 19
METOPROLOL TARTRATE 227 202 20 6
LIPITOR 211 211 21 51
DEXILANT 203 199 22 118
LIDODERM 190 185 23 59
SIMVASTATIN 190 158 23 1
GLIMEPIRIDE 186 186 25 37
MECLIZINE HCL 177 174 26 81
AVODART 176 176 27 107
OMEPRAZOLE 174 140 28 3
LOVAZA 173 169 29 43
LOSARTAN POTASSIUM 160 130 30 14
DIGOXIN 155 155 31 56
NAMENDA 154 154 32 47
CREON 154 154 32 111
NIFEDIPINE ER 151 142 34 48
POTASSIUM CHLORIDE 131 125 35 34
BYSTOLIC 128 127 36 96
NITROGLYCERIN PATCH 127 127 37 149
PANTOPRAZOLE SODIUM 120 106 38 61
RANITIDINE HCL 117 106 39 36
METFORMIN HCL 112 99 40 7
LOSARTAN-HYDROCHLOROTHIAZIDE 111 111 41 35
ISOSORBIDE DINITRATE 107 107 42 288
FLUTICASONE PROPIONATE 105 78 43 38
NITROSTAT 104 90 44 205
PRADAXA 103 103 45 192
BENICAR 103 103 45 100
RAMIPRIL 99 99 47 50
HYDROCHLOROTHIAZIDE 99 82 47 10
ACETAMINOPHEN-CODEINE 97 92 S3 49 127
LISINOPRIL 96 92 50 5
LANTUS SOLOSTAR 94 80 51 70
CILOSTAZOL 90 90 52 206
TRIAMTERENE-HCTZ 89 89 53 86
COLCRYS 89 89 53 170
VOLTAREN 81 79 55 97
PRAVASTATIN SODIUM 81 77 55 23
LEVOTHYROXINE SODIUM 80 58 57 4
DIOVAN HCT 80 78 57 39
ESCITALOPRAM OXALATE 78 74 59 89
CELEBREX 78 67 59 80
ADVAIR DISKUS 75 74 61 32
ENALAPRIL MALEATE 75 72 61 22
ALENDRONATE SODIUM 75 68 61 18
CLONIDINE HCL 75 74 61 79
COMBIVENT 74 69 65 156
IBUPROFEN 73 71 66 72
SPIRONOLACTONE 71 71 67 88
PROCTOZONE-HC 71 71 67 171
LEXAPRO 68 64 69 193
ONGLYZA 67 64 70 153
DILTIAZEM 24HR CD 67 67 70 119
BENICAR HCT 67 67 70 110
LANSOPRAZOLE 65 63 73 113
TRAMADOL HCL 65 65 73 40
GLYBURIDE-METFORMIN HCL 64 62 R 75 76
DETROL LA 63 63 76 249
GABAPENTIN 62 50 77 21
VESICARE 61 61 78 210
AZITHROMYCIN 58 57 79 42
EXFORGE 56 54 80 126
TRIBENZOR 54 52 81 276
LACTULOSE 53 42 82 87
ZETIA 52 40 83 68
ALLOPURINOL 50 50 84 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.